Skip to content
10-Q

Quarterly Report

Verona Pharma plc

0001657312-24-000031

← back to feed
Filed
Nov 4, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 28, 2024 654.65M sh
Shares Diluted Q3 2024 · Sep 30, 2024 651.94M sh
Shares Diluted Q3 2024 · Sep 30, 2024 648.63M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 638.24M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 631.45M sh
Capex Q3 2024 · Sep 30, 2024 $45K
Capex Q3 2024 · Sep 30, 2023 $0
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$93.37M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$39.82M
Long Term Debt Q3 2024 · Sep 30, 2024 $120.01M
Long Term Debt Q3 2024 · Dec 31, 2023 $48.37M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $336.04M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $271.77M
Stockholders Equity Q3 2024 · Sep 30, 2024 $130.49M
Stockholders Equity Q3 2024 · Jun 30, 2024 $168.27M
Stockholders Equity Q3 2024 · Mar 31, 2024 $224.99M
Stockholders Equity Q3 2024 · Dec 31, 2023 $249.28M
Stockholders Equity Q3 2024 · Sep 30, 2023 $263.53M
Stockholders Equity Q3 2024 · Jun 30, 2023 $273.09M
Stockholders Equity Q3 2024 · Mar 31, 2023 $276.75M
Stockholders Equity Q3 2024 · Dec 31, 2022 $230.47M
Current Liabilities Q3 2024 · Sep 30, 2024 $27.95M
Current Liabilities Q3 2024 · Dec 31, 2023 $8.69M
Total Liabilities Q3 2024 · Sep 30, 2024 $251.33M
Total Liabilities Q3 2024 · Dec 31, 2023 $58.84M
Current Assets Q3 2024 · Sep 30, 2024 $364.25M
Current Assets Q3 2024 · Dec 31, 2023 $289.71M
Total Assets Q3 2024 · Sep 30, 2024 $381.82M
Total Assets Q3 2024 · Dec 31, 2023 $308.12M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.07
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.22
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.02
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.06
Eps Basic Q3 2024 · Sep 30, 2024 −$0.07
Eps Basic Q3 2024 · Sep 30, 2024 −$0.22
Eps Basic Q3 2024 · Sep 30, 2023 −$0.02
Eps Basic Q3 2024 · Sep 30, 2023 −$0.06
Sga Expense Q3 2024 · Sep 30, 2024 $35.2M
Sga Expense Q3 2024 · Sep 30, 2024 $104.67M
Sga Expense Q3 2024 · Sep 30, 2023 $13.35M
Sga Expense Q3 2024 · Sep 30, 2023 $35.38M
Net Income Q3 2024 · Sep 30, 2024 −$42.96M
Net Income Q3 2024 · Sep 30, 2024 −$139.59M
Net Income Q3 2024 · Mar 31, 2024 −$25.79M
Net Income Q3 2024 · Sep 30, 2023 −$14.69M
Net Income Q3 2024 · Sep 30, 2023 −$40.24M
Net Income Q3 2024 · Jun 30, 2023 −$8.81M
Net Income Q3 2024 · Mar 31, 2023 −$16.74M
Operating Income Q3 2024 · Sep 30, 2024 −$40.67M
Operating Income Q3 2024 · Sep 30, 2024 −$136.29M
Operating Income Q3 2024 · Sep 30, 2023 −$16.31M
Operating Income Q3 2024 · Sep 30, 2023 −$48.48M
Revenue Q3 2024 · Sep 30, 2024 $5.62M
Revenue Q3 2024 · Sep 30, 2024 $5.62M
Revenue Q3 2024 · Sep 30, 2023 $0
Revenue Q3 2024 · Sep 30, 2023 $0